Belt and Road Summit 2025- Deal-making

10–16 Sept 2025 | China (Hong Kong)

ProjectUpdated on 3 September 2025

Estelle Biovita

Daisy Tan

Business Development Officer at InnoHK Centre for Translational Stem Cell Biology

Hong Kong, China (Hong Kong)

About

Estelle Biovita LTD is a biotechnology company specializing in science-driven skincare and cosmeceutical innovation through its proprietary ingredient, STEM ELIXIR. This breakthrough formulation harnesses the regenerative power of human stem cell secretions to enhance skin repair and renewal. Specially designed for sensitive skin, STEM ELIXIR delivers research-backed benefits including anti-ageing effects, skin barrier restoration, and inflammation relief.

Project Location

  • China (Hong Kong)

Project Format

  • Public-Private Partnership Project

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Project Planning

Main Project Sector

  • Technology

Technology

  • Bio-Tech
  • Health Technology

Total Project Value

  • 500,000 USD or Below

Investment Capital Required

  • 1,000,001 to 2,500,000 USD

Interested Format of Cooperation

  • Joint Venture
  • Open for Negotiation
  • R&D Cooperation

Preferred Financing Model

  • Open for negotiation

Previous Funding Stage

  • None

Main Service(s) Required

  • Financial Services
  • Professional Services

Organisation

InnoHK Centre for Translational Stem Cell Biology

Hong Kong Science and Technology Park, China (Hong Kong)

Similar opportunities

  • Project

    Trophy Life Technology

    • No
    • Bio-Tech
    • Technology
    • Joint Venture
    • R&D Cooperation
    • Project Planning
    • Health Technology
    • Seed & Pre-Series
    • Financial Services
    • 500,000 USD or Below
    • Open for Negotiation
    • Open for negotiation
    • Professional Services
    • Requisition of Service
    • 1,000,001 to 2,500,000 USD
    • Public-Private Partnership Project

    Daisy Tan

    Business Development Officer at InnoHK Centre for Translational Stem Cell Biology

    Hong Kong, China (Hong Kong)

  • Project

    Facilitate Neural Remodeling in Stroke Rehabilitation by Brain-Computer Interfaces (BCI) and Personalized Wearable Robotic Hands

    • Yes
    • None
    • Equity
    • Technology
    • Manufacturing
    • Private Project
    • 500,000 USD or Below
    • Open for Negotiation
    • Open for negotiation
    • Minority Shareholdings
    • 1,000,001 to 2,500,000 USD
    • Feasibility Study Completed
    • Information Technology Services

    XIANGQIAN SHI

    CEO at Hopebotics

    HONG KONG, China (Hong Kong)

  • Project

    Westelite - Biotech Skincare

    • No
    • None
    • Bio-Tech
    • Operations
    • Technology
    • E-commerce
    • Private Project
    • Open for negotiation
    • Minority Shareholdings
    • Transportation Services
    • 500,001 to 1,000,000 USD
    • 500,001 to 1,000,000 USD
    • Import & Export Solutions
    • Information Technology Services

    LU XU

    Founder at Westelite Capital

    Hangzhou, China